期刊文献+

MMP-9、TIMP-1和VEGF在视网膜母细胞瘤中的表达及意义 被引量:4

Expression of MMP-9,TIMP-1 and VEGF in retinoblastomaand its clinical significance
下载PDF
导出
摘要 目的探讨基质金属蛋白酶-9(MMP-9)、基质金属蛋白酶抑制剂-1(TIMP-1)和血管内皮生长因子(VEGF)在视网膜母细胞瘤(RB)中的表达及其与RB分化程度和视神经浸润的关系。方法应用MMP-9、TIMP-1单克隆抗体、VEGF多克隆抗体,采用PV6000免疫组化方法,对32例RB常规石蜡包埋标本进行MMP-9、TIMP-1和VEGF表达的测定。结果MMP-9和VEGF在RB中表达阳性率分别为56.25%(18/32)和68.75%(22/32),均与RB的分化程度及视神经浸润有关(P均<0.05)。TIMP-1的阳性表达率(18.75%,6/32)与RB的分化程度及视神经浸润无关(P>0.05)。MMP-9和VEGF在RB中的表达明显正相关(P<0.05)。结论MMP-9可以通过激活VEGF并上调VEGF的表达,促进RB组织中新生血管的生成。 [ Objective] To investigate the expression of matrixmetalloproteinase-9 (MMP-9), tissue inhibitor of metal- loproteinases-1 ( TIMP-1 ) and vascular endothelial growth factor (VEGF) in retinoblastoma (RB) and the relationship with the differentiation and optic nerve infiltration. [ Methods] The expression of MMP-9, TIMP-1 and VEGF was examined in 32 cases of RB tissue by using PV6000 immunohistochemistry. [ Results ] The positive rates of MMP-9 and VEGF were 56. 25% and 68.75 % respectively, and all the expression were significantly related to the differentiation degree and nerve infiltration (P 〈 0. 05 ). The positive rate of TIMP-1 expression was 18.75%, and not correlated with the differentiation degree and nerve infiltration (P 〉 0. 05). The expression of MMP-9 was positively correlated with the expression of VEGF in RB (P 〈0.05). [Conclusions] MMP-9 may activate VEGF, and promote the tumor angiogenesis of RB by up-regulating the expression of VEGF.
出处 《山东医药》 CAS 北大核心 2007年第19期53-55,共3页 Shandong Medical Journal
关键词 视网膜母细胞瘤 基质金属蛋白酶-9 血管内皮生长因子 retinoblastoma matrixmetaUoproteinase-9 vascular endothelial growth factor
  • 相关文献

参考文献5

二级参考文献29

  • 1徐和平,王成业,刘双珍,许雪亮,蒋幼芹,祝和成,李桂源,姚开泰.视网膜母细胞瘤细胞系HXO-Rb_(44)的建立及其生物学特性的检测[J].眼科研究,1994,12(3):183-186. 被引量:16
  • 2Still K,Robson CN,Autzen P,et al.Localization and quantification of mRNA for matrix metalloproteinase-2 (MMP-2) and tissue inhibitor of matrix metalloproteinase 2(TIMP-2) in human benign and malignant protatic tissue.Prostate,2000,42 (2):18-25. 被引量:1
  • 3Gohji K,Fujimoto N.Serum matrix metalloproteinase-2 and density in men with prostate cancer as a new predictor of disease extension.Int J Cancer,1998,79 (11):96-101. 被引量:1
  • 4Arii S,Mise M,Harada T,et al.Overexpression of matrix metalloproteinase-9 gene in hepatocellular carcinoma with invasive potential.Hapatolog,1996,24(2):316-319. 被引量:1
  • 5Okazaki L,Wada N,Nakano M,et al.Difference in gene expression for matrix metalloproteinase-1 between early and hepatocellular carcinomas.Hepatol,1997,25(3):580-584. 被引量:1
  • 6Hayasaka A,Suzuki N,Fujimoto N,et al.Elevated plasma levels of matrix metalloproteinase-9(92kd type collagenase / gelatinase B ) in hepatocellular carcinoma.Hepatol,1996,24 (5):1058-1062. 被引量:1
  • 7Nakatsukasa H,Ashida K,Higashi T,et al.Cellular distribution of transcripts for tissue inhibitor of metalloproteinase -1 and 2 in human hepatocellular carcinomas.Hepatol,1996,24 (1):82-86. 被引量:1
  • 8Hanemaaier R,Verheijen JH,Mayuire YM,et al.Increased gelatinase A and gelatinase-B activities in mallignant vs benign breast tumors.Int Cancer,2000,86,204-207. 被引量:1
  • 9Cawston T.Matrix metalloproteinases and TIMPs properties and implications for the rheumatic disease.Mol Med Today,1998,4(2):130-135. 被引量:1
  • 10Mitsiades N,Yu WH,Poulaki V,et al.Matrix metalloproteinase -7 mediated cleavage of Fas ligand protects tumor cells from chemotherapeutic drug cytotoxicity.Cancer Res,2001,61(2):577-581. 被引量:1

共引文献34

同被引文献50

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部